170 related articles for article (PubMed ID: 22716465)
1. Preparation and investigation of acetyl salicylic acid-caffeine complex for rectal administration.
Fouad EA; El-Badry M; Alanazi FK; Arafah MM; Al-Ashban R; Alsarra IA
Pharm Dev Technol; 2010 Jun; 15(3):249-57. PubMed ID: 22716465
[TBL] [Abstract][Full Text] [Related]
2. Preparation and investigation of acetyl salicylic acid-caffeine complex for rectal administration.
Fouad EA; El-Badry M; Alanazi FK; Arafah MM; Al-Ashban R; Alsarra IA
Pharm Dev Technol; 2009 Jul; ():. PubMed ID: 19640262
[TBL] [Abstract][Full Text] [Related]
3. A comparison of salicylic acid levels in normal subjects after rectal versus oral dosing.
Maalouf R; Mosley M; James Kallail K; Kramer KM; Kumar G
Acad Emerg Med; 2009 Feb; 16(2):157-61. PubMed ID: 19076101
[TBL] [Abstract][Full Text] [Related]
4. Release and rectal absorption of ethosuximide from suppositories in rabbits.
Ghazy FS; Mohamed MS; Kassem AA; Elhoseiny BM
Pharmazie; 1988 Jul; 43(7):484-5. PubMed ID: 3222279
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of sustained release suppositories prepared with fatty base including solid fats with high melting points.
Takatori T; Shimono N; Higaki K; Kimura T
Int J Pharm; 2004 Jul; 278(2):275-82. PubMed ID: 15196632
[TBL] [Abstract][Full Text] [Related]
6. Improvement of the rectal bioavailability of latamoxef sodium by adjuvants following administration of a suppository.
Nakanishi K; Masukawa T; Masada M; Nadai T
Biol Pharm Bull; 1994 Nov; 17(11):1496-500. PubMed ID: 7703971
[TBL] [Abstract][Full Text] [Related]
7. Utility of a rectal suppository containing the antiepileptic drug zonisamide.
Nagatomi A; Mishima M; Tsuzuki O; Ohdo S; Higuchi S
Biol Pharm Bull; 1997 Aug; 20(8):892-6. PubMed ID: 9300137
[TBL] [Abstract][Full Text] [Related]
8. Enhancement effect of lauric acid on the rectal absorption of propranolol from suppository in rats.
Ogiso T; Iwaki M; Kashitani Y; Yamashita K
Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2657-61. PubMed ID: 1806286
[TBL] [Abstract][Full Text] [Related]
9. [Morphine hydrochloride suppositories. II. Bioavailability of morphine hydrochloride suppositories in dogs].
Tan T; Kitamura K; Yamanaka M; Kojima K; Nakanishi Y; Arakawa S
Yakugaku Zasshi; 1990 Jun; 110(6):434-41. PubMed ID: 2213530
[TBL] [Abstract][Full Text] [Related]
10. Improvement by adjuvants on the rectal bioavailability of non-absorbable drugs following administration of suppository.
Nakanishi K; Masada M; Nadai T
J Pharmacobiodyn; 1990 Dec; 13(12):760-5. PubMed ID: 2098548
[TBL] [Abstract][Full Text] [Related]
11. The release of naproxen in fatty suppository bases by beta-cyclodextrin complexation.
Celebi N; Iscanoglu M; Degim T
Pharmazie; 1991 Dec; 46(12):863-5. PubMed ID: 1818322
[TBL] [Abstract][Full Text] [Related]
12. [Morphine hydrochloride suppositories. I. Bioavailability of morphine hydrochloride suppositories in rats].
Tan T; Kojima K; Nakanishi Y; Arakawa S
Yakugaku Zasshi; 1990 Jun; 110(6):426-33. PubMed ID: 2213529
[TBL] [Abstract][Full Text] [Related]
13. Correlation of in vitro and in vivo paracetamol availability from layered excipient suppositories.
Chicco D; Grabnar I; Skerjanec A; Vojnovic D; Maurich V; Realdon N; Ragazzi E; Belic A; Karba R; Mrhar A
Int J Pharm; 1999 Nov; 189(2):147-60. PubMed ID: 10536243
[TBL] [Abstract][Full Text] [Related]
14. Rectal absorption of acyclovir in rats and improvement of absorption by triglyceride base.
Ogiso T; Iwaki M; Tanino T; Fujii J; Paku T
Biol Pharm Bull; 1993 Mar; 16(3):315-8. PubMed ID: 8364481
[TBL] [Abstract][Full Text] [Related]
15. Studies on sustained-release suppositories. III. Rectal absorption of morphine in rabbits and prolongation of its absorption by alginic acid addition.
Kawashima S; Inoue Y; Shimeno T; Fujiwara H
Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):498-505. PubMed ID: 2337965
[TBL] [Abstract][Full Text] [Related]
16. [The dynamics of drug release from suppositories. Part 6: The effects of lipophil and hydrophilic suppository bases on the release of adeiphenin (author's transl)].
Pasich J; Brobnicka B; Kasprzyk A
Pharmazie; 1980; 35(7):416-7. PubMed ID: 6106209
[TBL] [Abstract][Full Text] [Related]
17. Isoniazid release from suppositories compounded with selected bases.
Hudson KC; Asbill CS; Webster AA
Int J Pharm Compd; 2007; 11(5):433-7. PubMed ID: 23969524
[TBL] [Abstract][Full Text] [Related]
18. [The dynamics of the drug release from suppositories. Part 5: Liberation of chlorpromazine from suppository bases (author's transl)].
Pasich J; Drobnicka B; Kasprzyk A
Pharmazie; 1981; 36(1):20. PubMed ID: 7220580
[TBL] [Abstract][Full Text] [Related]
19. Ketorolac tromethamine and ketoprofen suppositories: release profiles and bioavailability of a cocoa butter base formula in rabbits.
Zia H; Rashed SF; Quadir M; Needham TE; Squillante E
Int J Pharm Compd; 1998; 2(5):390-3. PubMed ID: 23989705
[TBL] [Abstract][Full Text] [Related]
20. The release of isoconazole nitrate from different suppository bases: in-vitro dissolution, physicochemical and microbiological studies.
Asikoglu M; Ertan G; Cosar G
J Pharm Pharmacol; 1995 Sep; 47(9):713-6. PubMed ID: 8583380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
